Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2349)	4/1/2008 1:12:56 PM
From: Jibacoa	Respond to of 3722

PGNX Is up 11.2% on volume of 969,133 which is now above its ADV The stock is starting to close its March 12 DG bigcharts.marketwatch.com It announced today that Wyeth has received marketing approval from the Canadian Regulatory Agency, for RELISTOR for subcutaneous injection in the treatment of opioid-induced constipation in patients with advanced illness receiving palliative care. The stock trades around 1.3xBV with a negative CF around $1.40 The short ratio is around 9x its ADV The Feb 2000 H was $96 <g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2349)	4/15/2008 12:05:21 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

PSTI was up 35.21% on volume of 302,742 almost 7x its ADV. bigcharts.marketwatch.com It announced today that a preclinical study utilizing its PLX cells showed a statistically significant advantage in ameliorating functional deficiencies in a standard MS animal model. PLX cells are mesenchymal stromal cells obtained from the placenta & expanded using PSTI's 3D PluriX technology. The stock had a good spike on Apr 7 & it seems that with a better general market,it could get again to the $6 level.The insiders hold around 10% & the float is < 4M. Bernard